[1]张娴 陈宏.新型脂肪因子与肥胖相关代谢性疾病[J].国际内分泌代谢杂志,2018,38(03):171-175.[doi:10.3760/cma.j.issn.1673-4157.2018.03.007]
 Zhang Xian,Chen Hong.Novel adipokines and obesity-related metabolic diseases[J].International Journal of Endocrinology and Metabolism,2018,38(03):171-175.[doi:10.3760/cma.j.issn.1673-4157.2018.03.007]
点击复制

新型脂肪因子与肥胖相关代谢性疾病()
分享到:

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
38
期数:
2018年03期
页码:
171-175
栏目:
综述
出版日期:
2018-05-20

文章信息/Info

Title:
Novel adipokines and obesity-related metabolic diseases
作者:
张娴 陈宏
510282 广州,南方医科大学珠江医院内分泌代谢科
Author(s):
Zhang Xian Chen Hong
Department of Endocrinology and Metabolism, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China
关键词:
脂肪组织 脂肪因子 肥胖 2型糖尿病 能量代谢
Keywords:
Adipose tissue Adipokines Obesity Type 2 diabetes mellitus Energy metabolism
DOI:
10.3760/cma.j.issn.1673-4157.2018.03.007
摘要:
肥胖是一种慢性低度炎性反应疾病,与代谢性疾病风险增加密切相关。研究表明,脂肪组织在体内代谢平衡调节中具有关键作用,不仅参与能量存储,并作为关键的内分泌器官,分泌具有促炎或抗炎活性的脂肪因子,参与胰岛素抵抗、2型糖尿病的发生。近期发现的几种新型脂肪细胞因子,如spexin、slit家族、adipolin、Wnt1诱导型信号通路蛋白2等在调节糖、脂代谢以及炎性反应等方面具有重要作用。
Abstract:
Obesity is a chronic low-grade inflammatory disease, which is closely related to the increased risk of metabolic diseases. Adipose tissue has been shown to play an essential role in regulating metabolic balance. Adipose tissue is not only involved in energy storage, but also as a key endocrine organ with secretion of pro-inflammatory or anti-inflammatory adipokines, participates in the occurrence of insulin resistance and type 2 diabetes mellitus. Recently, several novel types of cytokines have been found to play important roles in regulating glucose and lipid metabolism and inflammation, such as spexin, slit family, adipolin, Wnt1 inducible signaling pathway protein 2, and so on.

参考文献/References:


[1] Choe SS,Huh JY, Hwang IJ,et al. Adipose tissue remodeling: its role in energy metabolism and metabolic disorders[J].Front Endocrinol(Lausanne),2016,7:30.DOI:10.3389/fendo.2016.00030.
[2] Lee BC,Lee J.Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance[J].Biochim Biophys Acta,2014,1842(3):446-462.DOI:10.1016/j.bbadis.2013.05.017.
[3] Mirabeau O,Perlas E,Severini C,et al.Identification of novel peptide hormones in the human proteome by hidden Markov model screening[J].Genome Res,2007,17(3):320-327.DOI:10.1101/gr.5755407.
[4] Sonmez K,Zaveri NT,Kerman IA,et al.Evolutionary sequence modeling for discovery of peptide hormones[J].PLoS Comput Biol,2009,5(1):e1000258.DOI:10.1371/journal.pcbi.1000258.
[5] Walewski JL,Ge F,Gagner M,et al.Adipocyte accumulation of long-chain fatty acids in obesity is multifactorial, resulting from increased fatty acid uptake and decreased activity of genes involved in fat utilization[J].Obes Surg,2010,20(1):93-107.DOI:10.1007/s11695-009-0002-9.
[6] Walewski JL,Ge F,Lobdell H 4th,et al.Spexin is a novel human peptide that reduces adipocyte uptake of long chain fatty acids and causes weight loss in rodents with diet-induced obesity[J].Obesity(Silver Spring),2014,22(7):1643-1652.DOI:10.1002/oby.20725.
[7] Ge JF,Walewski JL,Anglade D,et al.Regulation of hepatocellular fatty acid uptake in mouse models of fatty liver disease with and without functional leptin signaling: roles of NfKB and SREBP-1C and the effects of spexin[J].Semin Liver Dis,2016,36(4):360-372.DOI:10.1055/s-0036-1597248.
[8] Kim DK,Yun S,Son GH,et al.Coevolution of the spexin/galanin/kisspeptin family: Spexin activates galaninreceptor type Ⅱ and Ⅲ[J].Endocrinology,2014,155(5):1864-1873. DOI:10.1210/en.2013-2106.
[9] Ma A,He M,Bai J,et al.Dual role of insulin in spexin regulation: functional link between food intake and spexin expression in a fish model[J].Endocrinology,2017,158(3):560-577.DOI:10.1210/en.2016-1534.
[10] Yang YH,Manning Fox JE,Zhang KL,et al.Intraislet SLIT-ROBO signaling is required for beta-cell survival and potentiates insulin secretion[J].Proc Natl Acad Sci U S A,2013,110(41):16480-16485.DOI:10.1073/pnas.1214312110.
[11] Glawe JD,Mijalis EM,Davis WC,et al.SDF-1-CXCR4 differentially regulates autoimmune diabetogenic T cell adhesion through ROBO1-SLIT2 interactions in mice[J].Diabetologia,2013,56(10):2222-2230.DOI:10.1007/s00125-013-2978-x.
[12] Svensson KJ,Long JZ,Jedrychowski MP,et al. A secreted Slit2 fragment regulates adipose tissue thermogenesis and metabolic function[J].Cell Metab,2016,23(3):454-466.DOI:10.1016/j.cmet.2016.01.008.
[13] Yamaguchi N,Argueta JG,Masuhiro Y,et al.Adiponectin inhibits Toll-like receptor family-induced signaling[J].FEBS Lett,2005,579(30):6821-6826. DOI:10.1016/j.febslet.2005.11.019.
[14] Enomoto T,Ohashi K,Shibata R,et al.Adipolin/C1qdc2/CTRP12 protein functions as an adipokine that improves glucose metabolism[J].J Biol Chem,2011,286(40):34552-34558.DOI:10.1074/jbc.M111.277319.
[15] Wei Z,Peterson JM,Lei X,et al.C1q/TNF-related protein-12(CTRP12), a novel adipokine that improves insulin sensitivity and glycemic control in mouse models of obesity and diabetes[J].J Biol Chem,2012,287(13):10301-10315.DOI:10.1074/jbc.M111.303651.
[16] Gray S,Wang B,Orihuela Y,et al.Regulation of gluconeogenesis by Krüppel-like factor 15[J].Cell Metab,2007,5(4):305-312.DOI:10.1016/j.cmet.2007.03.002.
[17] Enomoto T,Ohashi K,Shibata R,et al.Transcriptional regulation of an insulin-sensitizing adipokine adipolin/CTRP12 in adipocytes by Krüppel-like factor 15[J].PLoS One,2013,8(12):e83183.DOI:10.1371/journal.pone.0083183.
[18] Dahlman I,Elsen M,Tennagels N,et al.Functional annotation of the human fat cell secretome[J].Arch Physiol Biochem,2012,118(3):84-91.DOI:10.3109/13813455.2012.685745.
[19] Hammarstedt A,Hedjazifar S,Jenndahl L,et al.WISP2 regulates preadipocyte commitment and PPARγ activation by BMP4[J].Proc Natl Acad Sci U S A,2013,110(7):2563-2568.DOI:10.1073/pnas.1211255110.
[20] Chowdhury S,Wang X,Srikant CB,et al.IGF-I stimulates CCN5/WISP2 gene expression in pancreatic β-cells, which promotes cell proliferation and survival against streptozotocin[J]. Endocrinology,2014,155(5):1629-1642.DOI:10.1210/en.2013-1735.
[21] Almario RU,Karakas SE.Roles of circulating WNT-signaling proteins and WNT-inhibitors in human adiposity, insulin resistance, insulin secretion, and inflammation[J]. Horm Metab Res,2015,47(2):152-157.DOI:10.1055/s-0034-1384521.
[22] Grünberg JR,Hoffmann JM,Hedjazifar S,et al.Overexpressing the novel autocrine/endocrine adipokine WISP2 induces hyperplasia of the heart, white and brown adipose tissues and prevents insulin resistance[J].Sci Rep,2017,7:43515.DOI:10.1038/srep43515.
[23] Chakraborty A,Koldobskiy MA,Bello NT,et al.Inositol pyrophosphates inhibit Akt signaling, thereby regulating insulin sensitivity and weight gain[J].Cell,2010,143(6):897-910.DOI:10.1016/j.cell.2010.11.032.
[24] Ghoshal S,Zhu Q,Asteian A,et al.TNP[N2-(m-Trifluorobenzyl), N6-(p-nitrobenzyl)purine] ameliorates diet induced obesity and insulin resistance via inhibition of the IP6K1 pathway[J].Mol Metab,2016,5(10):903-917.DOI:10.1016/j.molmet.2016.08.008.
[25] Ghoshal S,Tyagi R,Zhu Q,et al.Inositol hexakisphosphate kinase-1 interacts with perilipin1 to modulate lipolysis[J].Int J Biochem Cell Biol,2016,78:149-155. DOI:10.1016/j.biocel.2016.06.018.
[26] Boregowda SV,Ghoshal S,Booker CN,et al.IP6K1 reduces mesenchymal stem/stromal cell fitness and potentiates high fat diet-induced skeletal involution[J].Stem Cells,2017,35(8):1973-1983.DOI:10.1002/stem.2645.

相似文献/References:

[1]刘美娟,朱惠娟,龚凤英.Glypican-,4与肥胖及胰岛素抵抗[J].国际内分泌代谢杂志,2015,(03):183.[doi:10.3760/cma.j.issn.1673-4157.2015.03.011]
 Liu Meijuan,Zhu Huijuan,Gong Fengying..Glypican-4 and obesity,insulin resistance[J].International Journal of Endocrinology and Metabolism,2015,(03):183.[doi:10.3760/cma.j.issn.1673-4157.2015.03.011]
[2]郑辉,葛焕琦.网膜素对心血管系统的影响[J].国际内分泌代谢杂志,2016,36(04):261.[doi:10.3760/cma.j.issn.1673-4157.2016.04.12]
 Zheng Hui,Ge Huanqi.Effects of omentin on cardiovascular system[J].International Journal of Endocrinology and Metabolism,2016,36(03):261.[doi:10.3760/cma.j.issn.1673-4157.2016.04.12]
[3]李耀辉,侯沃霖,刘芳.肥胖与脂肪组织慢性炎性反应[J].国际内分泌代谢杂志,2016,36(05):342.[doi:10.3760/cma.j.issn.1673-4157.2016.05.15]
 Li Yaohui,Hou Wolin,Liu Fang.Obesity and chronic inflammation in adipose tissue[J].International Journal of Endocrinology and Metabolism,2016,36(03):342.[doi:10.3760/cma.j.issn.1673-4157.2016.05.15]
[4]田清武,孙树凯,翟玉娥,等.雌激素对去卵巢大鼠内脏脂肪细胞脂肪因子表达水平的影响[J].国际内分泌代谢杂志,2016,36(06):374.[doi:10.3760/cma.j.issn.1673-4157.2016.06.04]
 Tian Qingwu*,Sun Shukai,Zhai Yue,et al.Effects of estrogen on the expression of adipokines in visceral fat cells in ovariectomized rats[J].International Journal of Endocrinology and Metabolism,2016,36(03):374.[doi:10.3760/cma.j.issn.1673-4157.2016.06.04]
[5]胡雯婧,朱惠娟,龚凤英.脂肪组织衰老与肥胖症关系的研究进展[J].国际内分泌代谢杂志,2023,43(06):492.[doi:10.3760/cma.j.cn121383-20220910-09019]
 Hu Wenjing,Zhu Huijuan,Gong Fengying..Research progress of adipose tissue senescence and obesity[J].International Journal of Endocrinology and Metabolism,2023,43(03):492.[doi:10.3760/cma.j.cn121383-20220910-09019]
[6]黄宝亮,黄晓燕,黄文森,等.新型脂肪因子FAM19A5在代谢性疾病中的研究进展[J].国际内分泌代谢杂志,2024,44(01):19.[doi:10.3760/cma.j.cn121383-20230220-02039]
 Huang Baoliang,Huang Xiaoyan,Huang Wensen,et al.Research progress of novel adipokine FAM19A5 in metabolic diseases[J].International Journal of Endocrinology and Metabolism,2024,44(03):19.[doi:10.3760/cma.j.cn121383-20230220-02039]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金(81570716,8177030041); 广东省自然科学基金(2016A030313633) Fund program:National Natural Science Foundation of China(81570716,8177030041); Natural Science Foundation of Guangdong Province of China(2016A030313633)
通信作者:陈宏,Email:chenhong82330@163.com Corresponding author: Chen Hong, Email: chenhong82330@163.com
更新日期/Last Update: 2018-03-30